Quantifying the role of immunotherapeutic drug T11 target structure in progression of malignant gliomas: mathematical modeling and dynamical perspective

From MaRDI portal
Publication:2408696

DOI10.1016/j.mbs.2017.04.006zbMath1378.92031OpenAlexW2609682509WikidataQ38810399 ScholiaQ38810399MaRDI QIDQ2408696

Subhas Khajanchi, Sandip Banerjee

Publication date: 13 October 2017

Published in: Mathematical Biosciences (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.mbs.2017.04.006




Related Items (25)

Discrete-time fractional order SIR epidemic model with saturated treatment functionThe impact of distributed time delay in a tumor-immune interaction systemDynamics of an HTLV-I infection model with delayed CTLs immune responseDynamics of tuberculosis transmission with exogenous reinfections and endogenous reactivationThe influence of time delay in a chaotic cancer modelThe impact of immunotherapy on a glioma immune interaction modelPhase-specific cancer-immune model considering acquired resistance to therapeutic agentsA new generalized fractional-order derivative and bifurcation analysis of cholera and human immunodeficiency co-infection dynamic transmissionA tumor-Immune interaction model with the effect of impulse therapyStability analysis of a mathematical model for glioma-immune interaction under optimal therapySpatiotemporal dynamics of a predator-prey system with fear effectGlobal stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastomaOPTIMAL TREATMENT STRATEGIES USING DENDRITIC CELL VACCINATION FOR A TUMOR MODEL WITH PARAMETER IDENTIFIABILITYRich dynamics of a predator-prey system with different kinds of functional responsesStability and Hopf bifurcations in a competitive tumour-immune system with intrinsic recruitment delay and chemotherapyInfluence of multiple delays in brain tumor and immune system interaction with T11 target structure as a potent stimulatorMathematical analysis of the global dynamics of a HTLV-I infection model, considering the role of cytotoxic T-lymphocytesModeling the dynamics of glioma-immune surveillanceMathematical modeling of tumor-immune competitive system, considering the role of time delayThe impact of the media awareness and optimal strategy on the prevalence of tuberculosisChaotic dynamics of a delayed tumor–immune interaction modelA STRATEGY OF OPTIMAL EFFICACY OF T11 TARGET STRUCTURE IN THE TREATMENT OF BRAIN TUMORSpatiotemporal dynamics of immunogenic tumorsIs the Allee effect relevant to stochastic cancer model?Optimal control and pattern formation for a haptotaxis model of solid tumor invasion




Cites Work




This page was built for publication: Quantifying the role of immunotherapeutic drug T11 target structure in progression of malignant gliomas: mathematical modeling and dynamical perspective